HSPA1A and amyotrophic lateral sclerosis: Another HDAC inhibitor, phenylbutyrate, is in clinical trial for ALS; however, phenylbutyrate had no effect on Hsp70 expression in heat shocked spinal cord-DRG cultures or on the efficacy of arimoclomol or NXD30001 (Online Resource 3).